Ca
Catalyst Bio (Vertex)
S San Francisco CAFounded 2015100 employees
Private CapbiotechAcquiredHematology
Platform: CTX-4430 SCD
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CAT-8632 | CAT-8632 | Phase 2/3 | 2 | IL-13 | PsoriasisSLE | ||
| Lisocilimab | CAT-2243 | Phase 2/3 | 2 | FXIa | Heart FailureLGS |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)